focus /
The hypoglycemia of little Osvaldo
Hypoglycemia and beta-blockers: new evidence from the real world and the scientific literature
Inglese
Hypoglycemia and beta-blockers: new evidence from the real world and the scientific literature
Innova SARS-CoV-2 Antigen Rapid Qualitative Test performance characteristics have not been adequately established, presenting a risk of false results.
The FDA has significant concerns that performance of the test has not been adequately established, presenting a risk to health.
Sodium Citrate Blood Specimen Collection Tube Conservation Strategies
The FDA has significant concerns that performance of the test has not been adequately established, presenting a risk to health.
Listing of the 2021 Biologics Recalls
Aziyo Biologics, Inc., (“Aziyo”) is the manufacturer of record for FiberCel Fiber Viable Bone Matrix (“FiberCel”) and is voluntarily recalling one Lot of the FiberCel product, Donor Lot Number: NMDS210011.
80.211.154.110